Výsledky vyhledávání

Akademický článek

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation

Autor: Erminia Ridolo, Cristoforo Incorvaia, Irene Martignago, Laura Pessina, Fulvio Lauretani, Luciano Loperfido, Gian Galeazzo Riario-Sforza, Annalisa Broglia, Bruna L. Gritti, Lorenzo Panella

Publikováno v: Clinical and Molecular Allergy, Vol 16, Iss 1, Pp 1-5 (2018)

Abstract Background Based on meta-analyses results, it is currently acknowledged that there is an increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) undergoing inhaled corticosteroids (ICS) treatment. However, t

Externí odkaz: https://doaj.org/article/45822007e2874952aad9adead881b1b6

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Local allergic rhinitis: evolution of concepts

Autor: Cristoforo Incorvaia, Nicola Fuiano, Irene Martignago, Bruna L. Gritti, Erminia Ridolo

Publikováno v: Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-4 (2017)

Abstract The discovery of an exclusive local production of IgE antibodies dates back to the 1970s, but only recently the pathophysiology of such phenomenon was deeply investigated, leading to the concept of local allergic rhinitis (LAR). Currently, L

Externí odkaz: https://doaj.org/article/218de1d3ded04245b78534534c95a6d9

Zobrazit plný text záznamu

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide

Autor: Bruna L. Gritti, Irene Pellicelli, Erminia Ridolo, Cristoforo Incorvaia

Publikováno v: Patient preference and adherence

Dual bronchodilation with long-acting beta-2 agonists and muscarinic antagonists is recommended in patients with severe to very severe COPD. Among dual bronchodilator combinations, indacaterol/glycopyrronium combination (IGC) received evidence of hig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6c2a41245c61033da30bc7cac5baa3
http://europepmc.org/articles/PMC6338236

Zobrazit plný text záznamu

Plný text ve formátu HTML

Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?

Autor: Eleni Makrì, Francesco Pucciarini, Erminia Ridolo, Cristoforo Incorvaia, Bruna L. Gritti

Publikováno v: Expert opinion on drug safety. 19(7)

Allergen immunotherapy is an effective treatment for respiratory allergy, but the administration to patients of extracts of the causative allergen may elicit systemic reactions, which include, particularly with subcutaneous immunotherapy (SCIT), anap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ab3bc9f9355e0f29d673a43fc0e767
https://pubmed.ncbi.nlm.nih.gov/32511028

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Local allergic rhinitis: evolution of concepts

Autor: Erminia Ridolo, Cristoforo Incorvaia, Irene Martignago, Nicola Fuiano, Bruna L. Gritti

Publikováno v: Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-4 (2017)
Clinical and Translational Allergy

The discovery of an exclusive local production of IgE antibodies dates back to the 1970s, but only recently the pathophysiology of such phenomenon was deeply investigated, leading to the concept of local allergic rhinitis (LAR). Currently, LAR is def

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47b6799354882e28bd5c16d71541090
http://link.springer.com/article/10.1186/s13601-017-0174-7

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation

Autor: Gian Galeazzo Riario-Sforza, Cristoforo Incorvaia, Erminia Ridolo, Lorenzo Panella, Irene Martignago, Fulvio Lauretani, Laura Pessina, Luciano Loperfido, Annalisa Broglia, Bruna L. Gritti

Publikováno v: Clinical and Molecular Allergy : CMA
Clinical and Molecular Allergy, Vol 16, Iss 1, Pp 1-5 (2018)

Background Based on meta-analyses results, it is currently acknowledged that there is an increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) undergoing inhaled corticosteroids (ICS) treatment. However, this is no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1155d01e19f317fe2cfa781bc02560f
https://doi.org/10.1186/s12948-018-0090-y

Zobrazit plný text záznamu

The economic advantage of allergen immunotherapy over drug treatment in respiratory allergy

Autor: Erminia Ridolo, Bruna L. Gritti, Cristoforo Incorvaia

Publikováno v: Journal of medical economics. 21(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4ed3720585dc0b76e651b7d4ac9eaea
https://pubmed.ncbi.nlm.nih.gov/29295630

Zobrazit plný text záznamu

Is there any further advance in bronchodilator combination therapy for COPD?

Autor: Cristoforo Incorvaia, Bruna L. Gritti, Erminia Ridolo

Publikováno v: Current Medical Research and Opinion. 36:125-126

Dear EditorThe birth of bronchodilators was driven by the understanding, about 60 years ago, that obstructive respiratory diseases could be reversible or irreversible, and that only bronchodilators...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2813353ee69a49e121b2bc9a17fdcfb1
https://doi.org/10.1080/03007995.2019.1676576

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání